In this week’s COVID-19 Grand Rounds session, Dr. Emily O’Brien of Duke University will present “HERO-Together: Building Vaccine Confidence With Long-Term Outcomes Data.” The Grand Rounds session will be held on Friday, January 8, at 1:00 pm eastern. Join the online meeting.

HERO-Together is a long-term safety study of the COVID-19 vaccine developed by Pfizer and BioNTech. In the study, the Duke Clinical Research Institute (DCRI) and Verily, with funding from Pfizer, are using the HERO Registry to gain long-term insights about the vaccine by following vaccinated healthcare workers for 2 years to assess their experiences after receiving the vaccine.

The NIH Collaboratory Coordinating Center is using its popular Grand Rounds platform to share late-breaking research and promote resources in support of clinical researchers affected by the COVID-19 public health emergency.

For previous COVID-19 Grand Rounds, and more news and resources related to the COVID-19 public health emergency, see the COVID-19 Resources page.